Literature DB >> 2268581

Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia.

A L Børresen1, T I Andersen, S Tretli, A Heiberg, P Møller.   

Abstract

Patients who are homozygous for ataxia-telangiectasia (AT) have an exceptionally high incidence of cancer. Heterozygous individuals for the disease have been reported to be at an increased risk of cancer, particularly breast cancer in female carriers. We have analyzed eight Norwegian families with AT for cancer incidence in the parents, in the parents' sibs, grandparents, and grandparents' sibs. Two of the obligate heterozygote females have had premenopausal breast cancer. This incidence is significantly higher than expected for that group. No increase in the cancer incidence was observed in the parents' sibs, the grandparents, or the grandparents' sibs. Since the incidence of AT is low, data from many sources have to be combined to allow any conclusion.

Entities:  

Mesh:

Year:  1990        PMID: 2268581     DOI: 10.1002/gcc.2870020412

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  30 in total

Review 1.  The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone.

Authors:  R A Gatti; S Becker-Catania; H H Chun; X Sun; M Mitui; C H Lai; N Khanlou; M Babaei; R Cheng; C Clark; Y Huo; N C Udar; R K Iyer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

2.  ATM protein synthesis patterns in sporadic breast cancer.

Authors:  R Kairouz; R A Clarke; P J Marr; D Watters; M F Lavin; J H Kearsley; C S Lee
Journal:  Mol Pathol       Date:  1999-10

Review 3.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

4.  Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.

Authors:  Shaun P Scott; Regina Bendix; Philip Chen; Raymond Clark; Thilo Dork; Martin F Lavin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

5.  Role of the ataxia-telangiectasia gene (ATM) in breast cancer. A-T heterozygotes seem to have an increased risk but its size is unknown.

Authors:  M Lavin
Journal:  BMJ       Date:  1998-08-22

6.  Association between ATM 5557G>A polymorphism and breast cancer risk: a meta-analysis.

Authors:  Chen Mao; Vincent C H Chung; Ben-Fu He; Rong-Cheng Luo; Jin-Ling Tang
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

7.  Astrocytoma linked to familial ataxia-telangiectasia.

Authors:  K Miyagi; J Mukawa; N Kinjo; K Horikawa; S Mekaru; S Nakasone; H Koga; Y Higa; M Naito
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 8.  Familial breast cancer and genes involved in breast carcinogenesis.

Authors:  A Lindblom
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

9.  Absence of linkage to the ataxia telangiectasia locus in familial breast cancer.

Authors:  R Wooster; D Ford; J Mangion; B A Ponder; J Peto; D F Easton; M R Stratton
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

10.  Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.

Authors:  Patrick Concannon; Robert W Haile; Anne-Lise Børresen-Dale; Barry S Rosenstein; Richard A Gatti; Sharon N Teraoka; T Anh Diep; Laila Jansen; David P Atencio; Bryan Langholz; Marinela Capanu; Xiaolin Liang; Colin B Begg; Duncan C Thomas; Leslie Bernstein; Jørgen H Olsen; Kathleen E Malone; Charles F Lynch; Hoda Anton-Culver; Jonine L Bernstein
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.